Doctor profile · Federal record
Dr. Asad Dean, MD
Hematology & Oncology Physician (CMS: Hematology/Oncology) · Medical Oncology Physician · Fort Worth, TX
- NPI 1760441885
- Accepts Medicare
- MIPS 86.7 / 100 · 2023
- 29 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
500 S Henderson St Ste 200
Fort Worth, TX 76104
(817) 413-1500
fax (817) 413-1499 - Mailing address
-
Po Box 911230
Dallas, TX 753911230
Credentials & registration
- NPI registered
- March 2006 — 20 yrs on file
- Profile last updated
- September 7, 2018
- Year of graduation
- 1997 — 29 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State license (1)
- Texas #L1557
- Medicaid (4)
- TX #162750701 · TX #162750707 · TX #162750703 · TX #162750704
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1760441885. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
40,161
Distinct HCPCS
10
Medicare allowed
$741,376
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J9271 |
Injection, pembrolizumab, 1 mg | 8,000 | 25 | $54 | |
J9025 |
Injection, azacitidine, 1 mg | 6,300 | 14 | $0 | |
J1756 |
Injection, iron sucrose, 1 mg | 6,200 | 17 | $0 | |
J9267 |
Injection, paclitaxel, 1 mg | 5,874 | 20 | $0 | |
J1453 |
Injection, fosaprepitant, 1 mg | 5,100 | 25 | $0 | |
J0897 |
Injection, denosumab, 1 mg | 1,320 | 12 | $23 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 1,126 | 63 | $0 | |
36415 |
Insertion of needle into vein for collection of blood sample | 701 | 270 | $8 | |
J1626 |
Injection, granisetron hydrochloride, 100 mcg | 660 | 34 | $0 | |
80053 |
Blood test, comprehensive group of blood chemicals | 633 | 261 | $10 |
In context: peer comparison
Among 10 peers in Fort Worth Hematology & Oncology Physician, average services per provider: 740. This provider delivers 54× the peer median.Open Payments
Industry payments received
All-time total
$112,028
Transactions
163
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Lilly USA, LLC | 101 | $80,087.70 | |
| Aveo Pharmaceuticals, INC. | 21 | $24,451.29 | |
| Janssen Biotech, INC. | 7 | $4,963.29 | |
| Abbvie INC. | 8 | $497.59 | |
| Genzyme Corporation | 4 | $338.97 | |
| AstraZeneca Pharmaceuticals Lp | 3 | $163.45 | |
| Genmab U.S., INC. | 2 | $158.59 | |
| Adaptive Biotechnologies Corporation | 1 | $154.90 | |
| Pfizer INC. | 2 | $153.08 | |
| Sobi, INC | 2 | $136.19 | |
| Myriad Genetic Laboratories, INC. | 1 | $120.79 | |
| Kite Pharma, INC. | 2 | $119.65 | |
| Astellas Pharma Global Development | 1 | $107.00 | |
| Novartis Pharmaceuticals Corporation | 5 | $99.61 | |
| Celgene Corporation | 3 | $75.19 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
576
Patients
109
Total drug cost
$508,836
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Prednisone | Generic | 71 | 14 | $599 |
| Eliquis (Apixaban) | Brand | 60 | 14 | $56,249 |
| Hydroxyurea | Generic | 56 | 11 | $2,641 |
| Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) | Brand | 46 | 20 | $1,673 |
| Letrozole | Generic | 46 | 12 | $1,216 |
| Acyclovir | Generic | 42 | 11 | $618 |
| Abiraterone Acetate | Generic | 35 | 0 | $46,274 |
| Anastrozole | Generic | 33 | 0 | $946 |
| Bicalutamide | Generic | 33 | 0 | $1,165 |
| Ondansetron Odt (Ondansetron) | Brand | 30 | 16 | $334 |
Hospital affiliations
Frequently asked questions
What is Dr. Asad Dean's medical specialty?
Dr. Asad Dean practices Hematology & Oncology Physician in Fort Worth, TX.
Where does Dr. Asad Dean practice?
Dr. Asad Dean practices at 500 S Henderson St Ste 200, Fort Worth, TX 76104. Office phone: 8174131500.
What is Dr. Asad Dean's NPI?
Dr. Asad Dean's National Provider Identifier (NPI) is 1760441885, issued by NPPES.
Does Dr. Asad Dean accept Medicare assignment?
Yes. Dr. Asad Dean accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Asad Dean commonly perform?
Top Medicare-reported procedures in 2023: Injection, pembrolizumab, 1 mg (HCPCS J9271); Injection, azacitidine, 1 mg (HCPCS J9025); Injection, iron sucrose, 1 mg (HCPCS J1756). Source: CMS Medicare Physician & Other Practitioners file.